[HTML][HTML] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - Elsevier
ABSTRACT Background The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …

Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening

U Pastorino, N Sverzellati, S Sestini, M Silva… - European journal of …, 2019 - Elsevier
Abstract Background The Multicentric Italian Lung Detection (MILD) trial demonstrated that
prolonged low-dose computed tomography (LDCT) screening could achieve a 39 …

Lung cancer mortality reduction by LDCT screening—results from the randomized German LUSI trial

N Becker, E Motsch, A Trotter… - … journal of cancer, 2020 - Wiley Online Library
In 2011, the US National Lung Cancer Screening Trial (NLST) reported a 20% reduction of
lung cancer mortality after regular screening by low‐dose computed tomography (LDCT), as …

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

JK Field, D Vulkan, MPA Davies… - The lancet regional …, 2021 - thelancet.com
Background The NLST reported a significant 20% reduction in lung cancer mortality with
three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - Thorax, 2017 - thorax.bmj.com
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …

Low‐dose computed tomography lung cancer screening: Clinical evidence and implementation research

HL Lancaster, MA Heuvelmans… - Journal of Internal …, 2022 - Wiley Online Library
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …

[HTML][HTML] Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial

National Lung Screening Trial Research Team - Journal of Thoracic …, 2019 - Elsevier
Abstract Introduction The National Lung Screening Trial (NLST) randomized high-risk
current and former smokers to three annual screens with either low-dose computed …

Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography

A Sadate, BV Occean, JP Beregi, A Hamard… - European Journal of …, 2020 - Elsevier
Introduction Lung cancer (LC) has the highest cancer mortality worldwide with poor
prognosis. Screening with low-dose computed tomography (LDCT) in populations highly …

Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force

DE Jonas, DS Reuland, SM Reddy, M Nagle, SD Clark… - Jama, 2021 - jamanetwork.com
Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

[HTML][HTML] Targeting of low-dose CT screening according to the risk of lung-cancer death

SA Kovalchik, M Tammemagi, CD Berg… - … England Journal of …, 2013 - Mass Medical Soc
Background In the National Lung Screening Trial (NLST), screening with low-dose
computed tomography (CT) resulted in a 20% reduction in lung-cancer mortality among …